Retired PwC Tax Partner, Ken Hagen, joins the board of AMRI
AMRI has announced the appointment of Kenneth P. Hagen, a former tax partner at PwC, to its Board of Directors. Mr. Hagen will join AMRI’s board in May 2016.
Mr. Hagen joined PwC in 1975 and became a tax partner in 1986, serving a wide range of pharmaceutical, industrial and technology clients. Since 2000 and until his retirement in 2011, Ken was the Partner-in-Charge of PwC’s Mergers and Acquisition tax practice in Philadelphia. In addition, Ken served as principal tax advisor for over a decade to one of the world’s leaders in generic pharmaceuticals. He also advised other clients on tax issues associated with large and diverse corporate transactions. Mr. Hagen is a CPA and holds a BS in Accounting from Pennsylvania State University and a Masters in Taxation from Villanova University.
Albany Molecular Research Inc. (AMRI) is a global contract research and manufacturing organization that has been working with the Life Sciences industry to improve patient outcomes and the quality of life for more than two decades.